• Novartis CEO plans gene therapy price far lower than $4 million to $5 million range
    Novartis AG’s top executive said on Wednesday it expects to price its gene therapy for spinal muscular atrophy “far lower” than the $4 million to $5 million figure the Swiss drugmaker has said it could be worth.

  • AveXis receives FDA approval for Zolgensma®, the first and only gene therapy for pediatric patients with spinal muscular atrophy (SMA)
    AveXis, a Novartis company, today announced the US Food and Drug Administration (FDA) has approved Zolgensma® (onasemnogene abeparvovac-xioi) for the treatment of pediatric patients less than 2 years of age with spinal muscular atrophy (SMA) with bi-allelic mutations in the survival motor neuron 1 (SMN1) gene.

  • Johns Hopkins Researchers Create Novel Cell Model of Aging-Related Colon Cancer Risk
    Johns Hopkins Kimmel Cancer Center researchers say a new study of clusters of mouse cells known as “organoids” has significantly strengthened evidence that epigenetic changes, common to aging, play a essential role in colon cancer initiation.

  • The number of knowledge-based products in the field of stem cells has increased
    Today, more than 80 knowledge-based companies are active in the field of stem cells, entrance of products of which to the society has increased hope in patients.

  • Medical equipment of Iran will be exhibited in the largest fair of the world
    The 5th national pavilion of Iranian products will be held in medical equipment exhibition (MEDICA) in Dusseldorf, Germany.

 

 

 

Vice-presidency News
Medical equipment of Iran will be exhibited in the largest fair of the world
The 5th national pavilion of Iranian products will be held in medical equipment exhibition (MEDICA) in Dusseldorf, Germany.
 11:40 - 22/05/2019 - Comments : 0More >>
Booming of the regenerative and cellular medicine is initiated/establishing the clean room of Kerman University of Medical Sciences
According to the public relations and information center of the Vice-Presidency for science and technology affairs,Sorena Sattari, the vice president for science and technology affairs, visited Kerman University of Medical Sciences to put the support of the formation and establishment of the first clean room in this university of the agenda of the Vice-Presidency.
 12:40 - 27/04/2019 - Comments : 0More >>
World News
Novartis CEO plans gene therapy price far lower than $4 million to $5 million range
Novartis AG’s top executive said on Wednesday it expects to price its gene therapy for spinal muscular atrophy “far lower” than the $4 million to $5 million figure the Swiss drugmaker has said it could be worth.
 11:12 - 25/05/2019 - Comments : 0More >>
AveXis receives FDA approval for Zolgensma®, the first and only gene therapy for pediatric patients with spinal muscular atrophy (SMA)
AveXis, a Novartis company, today announced the US Food and Drug Administration (FDA) has approved Zolgensma® (onasemnogene abeparvovac-xioi) for the treatment of pediatric patients less than 2 years of age with spinal muscular atrophy (SMA) with bi-allelic mutations in the survival motor neuron 1 (SMN1) gene.
 11:05 - 25/05/2019 - Comments : 0More >>
Council News
The number of knowledge-based products in the field of stem cells has increased
Today, more than 80 knowledge-based companies are active in the field of stem cells, entrance of products of which to the society has increased hope in patients.
 11:44 - 22/05/2019 - Comments : 0More >>
We move in line with the world in the field of gene therapy development
The president of the fifth symposium on genetics and stem cells with a gene therapy approach regarded this area as one of the fields that have had suitable improvements with the help of the researchers of the country.
 11:36 - 22/05/2019 - Comments : 0More >>
National News
The book of Science and Technology in Iran: A Brief Review was published
Deputy for international affairs and technological exchange aimed to publish the book of Science and Technology in Iran: A Brief Review considering its mission in the field of international cooperation in science and technology with the aim of introducing some of the capabilities of technology with the approach of developing technology diplomacy.
 10:49 - 15/05/2019 - Comments : 0More >>
Winners of the third round of the international Mustafa Prize will be announced in November 2019
The head of the administrative working group of the Mustafa Prize stated: the third international Mustafa Prize will be granted to the winners of this round on November 11th, 2019.
 13:01 - 27/04/2019 - Comments : 0More >>